These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6395653)

  • 1. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.
    Doherty PC; Knowles BB; Wettstein PJ
    Adv Cancer Res; 1984; 42():1-65. PubMed ID: 6395653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
    Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
    Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of MHC-linked, T cell-mediated suppression is regulated by the T cell genotype.
    Araneo BA
    J Mol Cell Immunol; 1986; 2(4):219-31. PubMed ID: 2855403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innate immune response to tumors and its role in the induction of T-cell immunity.
    Diefenbach A; Raulet DH
    Immunol Rev; 2002 Oct; 188():9-21. PubMed ID: 12445277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to escape immune surveillance?
    Zinkernagel RM
    Springer Semin Immunopathol; 1982; 5(1):107-12. PubMed ID: 6821229
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological surveillance against neoplasia: an immunological quandary.
    Drew SI
    Hum Pathol; 1979 Jan; 10(1):5-14. PubMed ID: 107113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance?
    Liu Y; Zheng P
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S61-4. PubMed ID: 11665749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of T-T lymphocytes and T-accessory cell interactions using cloned T cells: MHC I restricted cloned T cells activate MHC II restricted T helper cells.
    Brückner T; Di Pauli R
    Cell Immunol; 1986 Apr; 99(1):182-95. PubMed ID: 2875800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T cell receptors in non-MHC-restricted cytotoxicity.
    Lauzon RJ; Siminovitch KA; Roder JC
    Cell Immunol; 1989 Feb; 118(2):265-84. PubMed ID: 2521308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of tumor escape from immunologic response].
    Costello RT; Gastaut JA; Olive D
    Rev Med Interne; 1999 Jul; 20(7):579-88. PubMed ID: 10434348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific T cell clones restricted to unique F1 major histocompatibility complex determinants. Inhibition of proliferation with monoclonal anti-Ia antibody.
    Sredni B; Matis LA; Lerner EA; Paul WE; Schwartz RH
    J Exp Med; 1981 Mar; 153(3):677-93. PubMed ID: 6166704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologies between cell interaction molecules controlled by major histocompatibility complex- and Igh-V-linked genes that T cells use for communication; both molecules undergo "adaptive" differentiation in the thymus.
    Yamauchi K; Flood PM; Singer A; Gershon RK
    Eur J Immunol; 1983 Apr; 13(4):285-91. PubMed ID: 6343093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
    Morrison BJ; Steel JC; Morris JC
    BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.